The hormone can only be found sporadically in the maternal circulation. In contrast, it is consistently present in the faetal umbilical circulation at the time of delivery. Studies at Cesarean section indicate that foetal release of oxytocin occurs only during labour. These results suggest that the human faetus may play a part in its own delivery. Mr Mostyn P Embrey (Nuffield Department of Obstetrics & Gynacology, Radcliffe Infirmary, Oxford) Prostaglandins In Oxford our interest in the prostaglandins was greatly stimulated when we demonstrated in vitro (Embrey & Morrison 1968 ) that, contrary to earlier opinion, the E prostaglandins (PGEs) exhibit even more marked uterotonic effects than those of the Fa series (PGFs). We went on to an in vivo study (Embrey 1969 ) and preliminary work soon confirmed the striking oxytocic properties of the PGEs (compared with the PGFs) and also showed the labourinducing effect of (in retrospect) very small amounts of E prostaglandin.
There are now several series demonstrating the potential value of prostaglandins in the induction of labouraltogether some hundreds of cases. Results in our own study with intravenous PGEs are summarized in Table 1 and show that induction of labour was successful in 40 out of 42 patients. The effective dose range was 0-5-2 pg/min, the mean total dose of PGE 463 pg, and the mean infusion time 7 9 hours.
Prostaglandins E2 and F2a are at present being compared in controlled trials, but meantime Professor S Karim's larger experience confirms our own impression of the superiority of PGE, The prostaglandins are certainly effective oxytocics and in the dosage used relatively free from side-effects. Whether they will usurp oxytocin in the induction and maintenance of labour will probably depend chiefly on any tendency to produce hypertonus compared with oxytocin. We are actively studying this but experience so far suggests that one has much greater leeway regarding dosage than with oxytocin. I have only once produced transient hypertonus at term and then only with a very high infusion rate.
Recently, the potential value of the prostaglandins in the induction of abortion has attracted much attention. Our results are very similar to Professor Karim's: using the E prostaglandins intravenously (in about ten times the dose necessary at term) we have succeeded in inducing abortion in over 90 % of patients. The results in 34 patients are summarized in Table 2 . Induction of abortion was successful in 32 patients. The dose range was 2-6 pg/min. The mean total dose was 3,500 pg and the mean induction/abortion time 19-7 hours.
Again PGE2 seems to have advantages over PGF2a, being ten times as potent and much less prone to cause the side-effects of vomiting and diarrhoea common with F2a. The one drawback is an occasional 'phlebitis' at the site of injection, mostly trivial, but in a few instances quite marked, though rapidly fading after infusion.
It would clearly be advantageous to avoid the need for prolonged intravenous infusion and it may be that eventually a prostaglandin analogue will provide the answer. Meanwhile, as a possible way of reducing the infusion time, we have been studying the synergistic action of PGE2 and oxytocin, and it seems that PGE2 sensitizes the pregnant uterus to the action of oxytocin.
Thus it is well known that early in pregnancy oxytocin is almost without effect on uterine contractility, but after infusion of PGE2 over several hours the addition of oxytocin markedly increases contractility (Fig 1) . We need to study this more fully, but have found that the addition of oxytocin after sufficient priming by PGE2 has often been rapidly followed by abortion, and it is my impression that the amount of prostaglandin and the infusion time can be reduced in this way. Thus the mean dose of PGE2 in the series presented was 3,500 pg and the mean induction/abortion time 19-7 hours. But in a small series given oxytocin for the terminal 1-3 hours to expedite abortion, the mean dose was 2,610 pg and the mean time 16 hours.
We have also been exploring other routes of administration. Several years ago I showed that intrauterine instillation of small amounts of prostaglandin could stimulate contractions of the non-pregnant premenstrual uterus (cited by Pickles 1966 ). Recently we have had promising results in the induction of abortion using prostaglandins by intrauterine instillation. A catheter is introduced through the cervix and serves to inject the prostaglandin solution into the extra-ovular space as well as a means of monitoring the uterine contractions. We have found that injections of 50-200 pg PGE2 at We have employed this method in 15 patients (PGE, 13 patients, PGF2a 2 patients). Induction of abortion was successful in 14 instances and in 11 the abortion was complete. The total dose of E2 required varied from 350-2,500 ,ug (mean 1,177 ,ug), while the infusion time varied from 7-5 to 34 hours (mean 18 hours) (Table 3) .
It might be expected that local absorption of prostaglandins by this route would be somewhat uncertain and unpredictable, but early results have been promising and the clinical effectiveness of the method seems to compare favourably with intravenous administration. Moreovcr, the mean total dose of prostaglandin required was but a fraction of that required by the intravenous route andeven more importantthere were few side-effects.
